sydney meeting ?, page-16

From my interpretation (and I may be wrong), they needed many more patients with severe COPD or Asthma in the trial. Although they had clear cut results from people with moderate problems, reducing the days impacted by the cold might not necessarily be enough of an incentive for them to justify Vap. As I said, I might have totally misinterpreted this message, but you should feel free to follow-up directly with Russ or Joe.